ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

Bayh To Receive ACCC Annual Award

February 8, 1980

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

NCAB Committee Approves Recompletion Of Support Contracts

October 7, 1988

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989